Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,500 shares at $362.05 ($559K) on 2021-10-19, disclosed to the SEC on 2021-10-21.
Open-market sale of $559k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $362.05 | 200 | $72K | 12.9% |
| 2 | $370.14 | 100 | $37K | 6.6% |
| 3 | $371.65 | 100 | $37K | 6.6% |
| 4 | $373.75 | 400 | $150K | 26.7% |
| 5 | $375.08 | 400 | $150K | 26.8% |
| 6 | $376.36 | 200 |
| $75K |
| 13.5% |
| 7 | $377.71 | 100 | $38K | 6.8% |
| Total | $372.78 avg | 1,500 | $559K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-09-22 | $3.6M | — | Filing → |